1-5 of 5
Heike Reinhardt
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Revised Myeloma Comorbidity Index (R-MCI) As a Promising Approach for Predicting Overall (OS)- and Progression-Free (PFS) Survival and Optimizing Therapy Strategies in Multiple Myeloma (MM) Patients (pts) - Comparative Analysis of 5 Comorbidity Indices (CI), Including Retro- and Prospective Applicability

Katja Schoeller, Gabriele Ihorst, Sophia Scheubeck, Max Holler, Sandra M. Woerner, Heike Reinhardt, Stefan P. Müller, Justus Duyster, MD, Ralph Wäsch, MD, Monika Engelhardt, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3474.
https://doi.org/10.1182/blood-2019-127030
Published: 2019
Journal Articles

Navigating the Changing Multiple Myeloma (MM) Treatment Landscape: Real-World Data on Clinical Practice Patterns in 287 MM Patients Treated in and Outside German DSMM (Deutsche Studiengruppe Multiples Myelom) Study Group Trials

Laura Gengenbach, Heike Reinhardt, PhD, Stefanie Ajayi, Pharmacist, Magdalena Szymaniak-Vits, Pharmacist, Martin Köhler, MSc, Stefan J. Müller, PharmD, Sandra M. Dold, MSc, Martin J. Hug, PhD, Markus Ruch, Martin Boeker, PD, Hermann Einsele, Justus Duyster, Ralph Wäsch, MD, Monika Engelhardt
Journal: Blood
Blood (2017) 130 (Supplement 1): 3105.
https://doi.org/10.1182/blood.V130.Suppl_1.3105.3105
Published: 2017
Journal Articles

Results of an Open, Non-Comparative, Phase I/II Investigator Initiated Trial (IIT) in Relapsed or Refractory Multiple Myeloma Patients Using Vorinostat, Bortezomib, Doxorubicin and Dexamethasone (VBDD)

Alexander Keller, MD, Johannes M. Waldschmidt, MD, Dagmar Wider, Dorothee Jakobs, Mandy Möller, Heike Reinhardt, Milena Pantic, PhD, Olga Grishina, MD, Gabriele Ihorst, PhD, Annette M May, MD, Anna Frey, MD, Ulrike Kohlweyer, PhD, Justus Duyster, MD PhD, Manfred Jung, PhD, Monika Engelhardt, MD PhD, Ralph Wäsch, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4260.
https://doi.org/10.1182/blood.V126.23.4260.4260
Published: 2015
Journal Articles

Vorinostat (V) In Combination With Bortezomib (B), Doxorubicin (D) and Dexamethasone (D) (VBDD) In Patients With Refractory Or Relapsed Multiple Myeloma: An Interim Phase I/II Analysis

Martina Kleber, Dagmar Wider, Kristina Keller, Barbara Groß, Heike Reinhardt, Dorothee Jakobs, Mandy-Deborah Moeller, Manuela Burbeck, Milena Pantic, Annette May, Manfred Jung, PhD, Ralph Waesch, MD, Monika Engelhardt, MD
Journal: Blood
Blood (2013) 122 (21): 3202.
https://doi.org/10.1182/blood.V122.21.3202.3202
Published: 2013
Journal Articles

The Risk of Vascular and Thromboembolic Events Is Increased In Young Low-Risk Germ Cell Cancer Patients by Cisplatin Containing Chemotherapy

Leticia M Solari, Kathrin Dollinger, Jürgen Heinz, Heike Reinhardt, Susanne Rohdenburg, Monika Engelhardt, Cornelius F. Waller
Journal: Blood
Blood (2010) 116 (21): 5119.
https://doi.org/10.1182/blood.V116.21.5119.5119
Published: 2010